Evidence map›Paper›PMID 36379614›Full record

ArticleJournal of Zhejiang University. Science. B2022

A method for distinguishing benign and malignant pulmonary nodules based on 3D dual path network aided by

Dachuan Gao, Xiaodan Ye, Xuewen Hou, Yang Chen, Xue Kong, Yuanzhong Xie, Shengdong Nie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dachuan GaoSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Xiaodan YeDepartment of Radiology, Shanghai Chest Hospital, Shanghai 200030, China.
Xuewen HouSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Yang ChenSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Xue KongMedical Imaging Center, Tai'an Center Hospital, Tai'an 271000, China.
Yuanzhong XieMedical Imaging Center, Tai'an Center Hospital, Tai'an 271000, China. xie01088@126.com.
Shengdong NieSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China. xie01088@126.com, nsd4647@163.com.

Funding

the National Natural Science Foundation of China 81830052the Science and Technology Innovation Action Plan of Shanghai 18441900500the Shanghai Natural Science Foundation of China 20ZR1438300
6 · The paper itself

Abstract

In the USA, there were about 1 ‍806 ‍590 new cancer cases in 2020, and 606 520 cancer deaths are expected to have occurred in 2021. Lung cancer has become the leading cause of death from cancer in both men and women (Siegel et al., 2020). Clinical studies show that the five-year survival rate of lung cancer patients after early diagnosis and treatment intervention can reach 80%, compared with that of patients having advanced lung cancer. Thus, the early diagnosis of lung cancer is a key factor to reduce mortality.

Indexed as

Lung NeoplasmsTomography, X-Ray ComputedAlgorithmsCluster AnalysisFemaleHumansMale

Identifiers

PMID36379614
PMCPMC9676095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.